(Q36496834)

14 August 2017

Effects of L-carnitine in patients with hepatic encephalopathy (English)

1 reference

14 August 2017

Mariano Malaguarnera

1

1 reference

14 August 2017

Giovanni Pistone

2

1 reference

14 August 2017

Rampello Elvira

3

1 reference

14 August 2017

Carmelo Leotta

4

1 reference

14 August 2017

Linda Scarpello

5

1 reference

14 August 2017

Rampello Liborio

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

11

1 reference

14 August 2017

7197-7202

1 reference

14 August 2017

45

1 reference

Brain edema and portal-systemic encephalopathy

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

The role of carnitine supplementation during valproic acid therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Transection of the oesophagus for bleeding oesophageal varices

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Relationship between unusual hepatic acyl coenzyme A profiles and the pathogenesis of Reye syndrome.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Ammonia: key factor in the pathogenesis of hepatic encephalopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Astrocytic-ammonia interactions in hepatic encephalopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

[Direct determination of plasma ammonia without deproteinization. An improved enzymic determination of ammonia, II (author's transl)]

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Suppression of neurotoxicity of ammonia by L-carnitine

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

L-Carnitine in the treatment of mild or moderate hepatic encephalopathy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Influence of intravenous L-carnitine administration in sheep preceding an oral urea drench.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4725086

Objective measurement of hepatic encephalopathy by means of automated EEG analysis

21 September 2018

1 reference

12 December 2020

Hepatotoxicity in rat following administration of valproic acid: effect of L-carnitine supplementation

1 reference

12 December 2020

Effect of orally administered L-carnitine on blood ammonia and L-carnitine concentrations in portacaval-shunted rats

1 reference

12 December 2020

Ammonia and glutamine metabolism in human liver slices: new aspects on the pathogenesis of hyperammonaemia in chronic liver disease

1 reference

12 December 2020

Acyl-CoA esters of xenobiotic carboxylic acids as biochemically active intermediates

1 reference

12 December 2020

Effect of L-carnitine on ketone bodies, redox state and free amino acids in the liver of hyperammonemic mice

1 reference

12 December 2020

Prevention of ammonia toxicity by L-carnitine: metabolic changes in brain

1 reference

12 December 2020

Carnitine deficiency and hyperammonemia associated with valproic acid therapy

1 reference

12 December 2020

Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment

1 reference

12 December 2020

Changes in distribution and activity of glutamine synthetase in carbon tetrachloride-induced cirrhosis in the rat: potential role in hyperammonemia

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V11.I45.7197

1 reference

14 August 2017

1 reference

14 August 2017

1 reference